The Directorate General of the Health Service (DGHS) is intended to inform the rules that order minimal standards for the collection and transport of samples to prevent compromise or contamination that could lead to inaccurate test results, according to the documents of the reviewed Mint and officials who are familiar with this matter.
The new standards to be announced soon are focused on solving regulatory gaps that led to a deterioration in the integrity of the samples and the outcome of the irregularities, especially in the growing sector of house collection. The proposed standards after the Drink Directive in Delhi will ensure that all samples, including blood, urine and swabs, are solved by trained experts and transported under the correct conditions, including maintaining a cold chain. The development assumes importance to the Indian diagnostic industry of $ 13 billion and provides them with a uniform and legally bound framework.
Standards important
According to experts in the diagnostic industry, the proposed standards are important due to the increase in sampling services and a widespread deficiency of consistency in how medical samples are collected, stored and transported. Pandemie Covid accelerated the demand for home testing, which led to the rapid establishment of numerous new laboratories. Although this widespread approach to testing has also brought a new set of challenges, as many of these devices were set up with a low end and operated on extremely slender profit margins. As a result, they often tried to attract good talent or invest in advanced equipment for specialized tests. This has led to insufficient quality standards, while the reports were generated without necessary checks and balance.
“Patients and the general public will feel the primary impact of the new policy. They will ensure that all diagnostic samples, whether blood, urine or swabs, are collected by trained experts according to strict protocols. This includes mandatory use of personal protective equipment (PPE), which is first official official.
Step towards reliability
Standardization is the decisive step to improve the reliability of test results, which directly leads to a more accurate diagnosis and effective therapeutic plans, the second official said.
The High Court in Delhi in his order 11. November 2022 stated that there was no law or regulation that regulates how diagnostic samples are collected, stored and transported, and ordered the government to break down and inform minimum standards.
The second official added that they provide instructions for healthcare workers. “Pathologists, technicians and collection agents will now have a legal standard that will be followed, which not only makes their work more efficient, but also minimizes the risk of degradation and contamination of samples,” the official said.
This policy orders the right storage conditions and determines clear time -free temporal timeouts, which is particularly essential for vulnerable or high -risk patients. This initiative provides the basis for responsibility and ensures that all clinical devices work with the highest degree of professionalism and security. It will serve as a powerful tool to promote quality control across the diagnostic landscape and increase the bar for the entire industry, the official added.
Questions to the Ministry of Health on Tuesday remained unanswered.
Welcome
Medical experts welcomed this step and stated that improper treatment, especially the lack of the right cold chain in the country with often significant climate in India, can seriously endanger samples and distort test results. Such inaccuracies can lead to incorrect diagnoses, inappropriate treatment and significant erosion of public confidence in the health system.
Dr. Sunita Kapoor, director and head of the Laboratory on the X-Ray & Scan Clinic, said that the new policy would require an initial financial investment from diagnostic companies. This investment will include basic areas such as employee training, facilities, cold chain management and quality control processes.
However, she stressed that, despite these initial expenditure, long -term benefits will be outweigh the initial costs. It believes that these investments will lead to long -term savings by improving efficiency and reducing operating inefficiency, such as a re -test.
Dr. Kapoor said that the increase in diagnostic centers will lead to a small increase in testing costs in patients. Over time, the focus on quality and standardization will not only improve patient care, but also ensure availability, which will be a reliable diagnosis accessible to several people. They argue that this approach will eventually reduce total expenditure, increase confidence and ensure sustainable growth of the industry without significant and permanent increase in costs in patients.
“In time and praise”
Dr. ARUN DANG, CEO. Dangs Lab, called the “in time and commendable” initiative. He stressed that the absence of uniform standards was a critical gap, and since most diagnostic errors occur in the preanalytic phase, these instructions will help ensure the integrity of the sample and ensure reliable results. He described the proposed policy as “a decisive step towards quality, responsibility and better patient care”.
International standards for collecting and transporting samples of medical samples are well introduced. The World Health Organization (WHO) provides instructions for safe transport of infectious substances, while the Institute of Clinical and Laboratory Standards based in the US (CLSI) offers detailed instructions for the preanalytic phase of testing. Countries such as the US and the countries in the European Union have strict regulations to ensure the integrity of the patient’s sample and safety.
Similarly, Dr. Shelly Mahajan, director of the Mahajan Imaging & Labs laboratory, stressed that while the rapid growth of the diagnostic sector has improved access, he also “revealed serious gaps in regulation and standardization”. She noted that even the most advanced laboratory could not bring accurate results if the sample it receives is at risk. The new policy will bring much needed uniformity and strengthen confidence in diagnostic results across the Indian ecosystem of health care.
(Tagstotranslate) Diagnostic Laboratory (T) Collection of Medical Samples (T) Domestic Section (T) Quality Control (T) Patient Care
